Koyfin Home > Directory > Health Care > Pieris Pharma > Gross Profit

Pieris Pharma Gross Profit Chart (PIRS)

Pieris Pharma annual/quarterly Gross Profit from 2013 to 2020. Gross profit is the profit after deducting the costs associated with making and selling its products, or the costs associated with providing its services. Gross profit = Revenue - Cost of Goods Sold.
  • Pieris Pharma Gross Profit for the quarter ending September 09, 2020 was $-9m a 294.42% decrease of -26m year over year
  • Pieris Pharma Gross Profit for the last 12 months ending September 09, 2020 was $50m a 6.85% increase of 3m year over year
  • Pieris Pharma Annual Gross Profit for 2019 was $46m a 37.12% increase of 17m from 2018
  • Pieris Pharma Annual Gross Profit for 2018 was $29m a 13.15% increase of 4m from 2017
  • Pieris Pharma Annual Gross Profit for 2017 was $25m a 76.93% increase of 19m from 2016
Other Income Statement Metrics:
  • Pieris Pharma EBITDA for the quarter ending September 09, 2018 was $-8m a 185.85% decrease of -14m year over year
  • Pieris Pharma Net Income for the quarter ending September 09, 2018 was $-6m a 221.74% decrease of -14m year over year
  • Pieris Pharma Total Revenue for the quarter ending September 09, 2018 was $8m a -117.52% decrease of -10m year over year
View Chart On Koyfin

Quarterly PIRS Gross Profit Data

09/2020$-9m
06/2020$0m
03/2020$1m
12/2019$17m
09/2019$2m
06/2019$-8m
03/2019$-6m
12/2018$5m
09/2018$8m
06/2018$12m

Annual PIRS Gross Profit Data

2019$46m
2018$29m
2017$25m
2016$6m
2015$3m
2014$5m
2013$12m
2012$11m